Revvity Inc. stock gains on Morgan Stanley conference momentum and strong valuation signals

Published on 09/15/2026 at 11:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revvity Inc. stock closed at USD 128.49 on September 14, 2026, just 3.4 percent higher on the day and close to its 52-week high of USD 133.00. Recent commentary highlights a GF Score of 77 out of 100 and consensus analyst price target of USD 116.57, underscoring mixed views on upside.

Labor mit Wissenschaftlerin an Sequenziergerät und Reagenzflaschen — Fotorealistisches Life-Sciences-Labor zeigt Revvity Inc. (ISIN US76155R1086) mit automatisiertem Sequenziergerät und Reagenzien, Illustration mit AI erstellt.

Revvity Inc. stock (ISIN US76155R1086) continued its positive run with shares closing at USD 128.49 on September 14, 2026 on the New York Stock Exchange, up 3.4 percent from the prior close and trading close to a 52-week high of USD 133.00 as investors digested fresh conference commentary and valuation signals.

Morgan Stanley healthcare conference spotlights strategy

On September 14, 2026, Revvity used the Morgan Stanley 24th Annual Global Healthcare Conference to outline how its portfolio and capital allocation have shifted in recent years, emphasizing diagnostics, life sciences tools and higher-margin businesses, according to Investing.com on September 14, 2026.

The company highlighted that disciplined capital deployment and portfolio reshaping have supported shareholder returns, with total return over the past year reported at about 50 percent and a 45 percent gain over the last six months, as management has been buying back shares, according to Investing.com.

Valuation metrics and GF Score frame investor debate

Fresh quantitative analysis puts the latest price performance in context: on September 14, 2026, Revvity Inc. shares were described as overvalued, trading at USD 128.49, roughly 9.4 percent above an estimated intrinsic value of USD 117.48 based on GF Value, with a GF Score of 77 out of 100 pointing to above-average financial health, according to GuruFocus on September 14, 2026.

The same analysis breaks down the GF Score components, noting profitability at 7 out of 10, valuation at 7 out of 10 and momentum at 9 out of 10, underscoring that price strength is the clearest factor in the current story, according to GuruFocus.

At the same time, consensus analyst data compiled as of mid September 2026 show an average price target of USD 116.57, implying about 7.8 percent downside from a recent spot price of USD 126.42, and a Hold consensus rating based on 18 analysts, according to MarketBeat.

Analyst ratings and longer-term expectations

Revvity Inc. currently carries a consensus Hold rating, with no strong sell calls, four buy ratings and 14 hold ratings, reinforcing the picture of a company viewed as fundamentally solid but not universally seen as cheap at current levels, according to MarketBeat.

One recent screening placed Revvity in a group of blue-chip stocks with a composite grade of B for overall quality, C for valuation and B for momentum, suggesting the shares blend solid business characteristics with strong price action but a richer valuation profile, according to InvestorPlace on September 14, 2026.

Looking further ahead, one fundamental scenario projects Revvity revenues of about USD 3.4 billion and earnings of USD 554.4 million by 2029, based on an assumed annual revenue growth rate of 4.9 percent and earnings up from roughly USD 237.4 million today, giving investors a sense of modest growth expectations over the coming years, according to Simply Wall St on September 14, 2026.

Risks: revenue momentum and geographic exposure

The same longer-term analysis highlights that declining or slower-growing revenue is central to the valuation debate, with some scenarios focusing on regulatory pressure in China and assuming revenues around USD 3.2 billion and earnings about USD 360.3 million by 2029, a more cautious path than the base case, according to Simply Wall St.

In the near term, insiders and institutional investors described as gurus have been trimming positions rather than adding, with five such investors reducing stakes in recent quarters, a pattern that some observers read as caution about valuation or future growth, according to GuruFocus.

Stock price level and trading context

Revvity Inc. shares closed at USD 128.49 on the New York Stock Exchange on September 14, 2026, with the move of 3.4 percent on the day leaving the stock just below a 52-week high of USD 133.00 and well above a 52-week low of USD 81.22, while recent trading has taken place on volumes around 798,307 shares and a market capitalization of roughly USD 14.11 billion as of mid September 2026, based on data compiled by MarketBeat and figures referenced by GuruFocus.